Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 1 | PDGF-BB | 35.0 | 68 | |
N2586 | EO1428 | 1.0 | uM | 1 | PDGF-BB | 33.5 | 34 | ||||
RA2159 | IL-1 alpha | 100 | ng/mL | 1 | PDGF-BB | 40.5 | 70 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 1 | PDGF-BB | 35.0 | 64 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | PDGF-BB | 32.5 | 78 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | PDGF-BB | 39.5 | 66 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | PDGF-BB | 33.0 | 60 | |
RA2159 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | PDGF-BB | 25.0 | 66 | |
RA2159 | PI103 | 0.1 | uM | 1 | PDGF-BB | 26.0 | 73 | ||||
N2586 | IL-1 alpha | 100 | ng/mL | 1 | PDGF-BB | 39.0 | 65 | ||||
N2586 | PD184352 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 1 | PDGF-BB | 37.0 | 53 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | PDGF-BB | 33.0 | 63 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | PDGF-BB | 40.5 | 54 | |
N2586 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | PDGF-BB | 42.5 | 52 | |
N2586 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | PDGF-BB | 33.0 | 40 | |
N2586 | PI103 | 0.1 | uM | 1 | PDGF-BB | 29.0 | 82 | ||||
RA2159 | IL-6 | 100 | ug/mL | 1 | PDGF-BB | 33.0 | 56 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-6 | 100 | ug/mL | 1 | PDGF-BB | 27.0 | 66 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | PDGF-BB | 27.5 | 90 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | PDGF-BB | 34.0 | 86 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | PDGF-BB | 27.0 | 63 | |
RA2159 | IKK16 | 2.0 | uM | IL-6 | 100 | ug/mL | 1 | PDGF-BB | 29.0 | 76 | |
RA2159 | Sigma A6730 | 3.0 | uM | 1 | PDGF-BB | 24.0 | 79 | ||||
N2586 | IL-6 | 100 | ug/mL | 1 | PDGF-BB | 30.0 | 86 | ||||
N2586 | PD184352 | 0.1 | uM | IL-6 | 100 | ug/mL | 1 | PDGF-BB | 25.5 | 64 |